Porter Derrell
SEC Form 4 insider trading activity
Porter Derrell has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 17, 2026.
On the most recent filing, Porter Derrell is listed as Director at Acumen Pharmaceuticals, Inc. Inside the rolling window, Porter Derrell reported no open-market purchases and 3 open-market sales totaling $75K in ABOS. The largest disclosed transaction in the window is a sale of 13,040 ABOS shares on Jun 17, 2026, worth $30K.
Companies traded
Other insiders at ABOS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$75K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Porter Derrell made?
Porter Derrell has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Porter Derrell trade?
Porter Derrell has filed SEC Form 4 disclosures for 1 company, including ABOS.
When was Porter Derrell's most recent SEC Form 4 filing?
Porter Derrell's most recent SEC Form 4 filing on Tracefour is dated Jun 17, 2026.
What is Porter Derrell's total buy and sell value in the current window?
Inside the rolling retention window, Porter Derrell bought $0 and sold $75K based on SEC Form 4 filings.
What was Porter Derrell's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 13,040 ABOS shares on 2026-06-17, worth $30K, per SEC Form 4 filings.